UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$440M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 3 |
CRH
CRH
|
+$275M |
| 4 |
Advanced Micro Devices
AMD
|
+$228M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$538M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$473M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$397M |
| 4 |
Microsoft
MSFT
|
+$366M |
| 5 |
UnitedHealth
UNH
|
+$312M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.42% |
| 2 | Financials | 6.7% |
| 3 | Healthcare | 6.28% |
| 4 | Consumer Discretionary | 5.01% |
| 5 | Industrials | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
3976
DELISTED
Verve Therapeutics
VERV
| $1.1M | ﹤0.01% |
83,263
-4,811
| -5% | -$77.5K |
|
3977
Regenxbio
RGNX
$704M
| $1.1M | ﹤0.01% |
66,998
+4,598
| +7% | +$83.3K |
|
3978
Apogee Enterprises
APOG
$888M
| $1.1M | ﹤0.01% |
23,412
-194
| -0.8% | -$9.43K |
|
3979
Rentokil
RTO
$12.1B
| $1.1M | ﹤0.01% |
29,730
-1,330
| -4% | -$50.8K |
|
3980
Iovance Biotherapeutics
IOVA
$2.95B
| $1.1M | ﹤0.01% |
241,388
-228,424
| -49% | -$1.49M |
|
3981
Clear Secure
YOU
$4.7B
| $1.1M | ﹤0.01% |
57,618
+3,211
| +6% | +$71.2K |
|
|
BGX
3982
Blackstone Long-Short Credit Income Fund
BGX
$139M
| $1.1M | ﹤0.01% |
94,041
+3,018
| +3% | +$34.8K |
|
|
KE
3983
Kimball Electronics
KE
$626M
| $1.09M | ﹤0.01% |
39,974
+12,213
| +44% | +$349K |
|
3984
Syndax Pharmaceuticals
SNDX
$1.7B
| $1.09M | ﹤0.01% |
75,357
-37,359
| -33% | -$707K |
|
|
MAG
3985
PUT
DELISTED
MAG Silver
MAG
| $1.09M | ﹤0.01% |
105,500
| – | – |
|
|
BCV
3986
Bancroft Fund
BCV
$144M
| $1.09M | ﹤0.01% |
69,236
-1,454
| -2% | -$24.6K |
|
3987
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
| $1.09M | ﹤0.01% |
83,515
-10,859
| -12% | -$153K |
|
3988
Zeta Global
ZETA
$7.44B
| $1.09M | ﹤0.01% |
130,705
+15,622
| +14% | +$129K |
|
3989
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $1.09M | ﹤0.01% |
62,814
+18,171
| +41% | +$306K |
|
3990
CALL
Exelixis
EXEL
$12.5B
| $1.09M | ﹤0.01% |
49,900
-53,300
| -52% | -$1.11M |
|
3991
CALL
Extreme Networks
EXTR
$3.16B
| $1.09M | ﹤0.01% |
+45,000
| New | +$1.22M |
|
|
VGR
3992
DELISTED
Vector Group Ltd.
VGR
| $1.08M | ﹤0.01% |
101,774
-81,560
| -44% | -$946K |
|
|
PRO
3993
DELISTED
PROS Holdings
PRO
| $1.08M | ﹤0.01% |
31,259
-3,701
| -11% | -$128K |
|
3994
Aaon
AAON
$7.23B
| $1.08M | ﹤0.01% |
19,022
-66,475
| -78% | -$4.22M |
|
|
EU
3995
enCore Energy
EU
$221M
| $1.08M | ﹤0.01% |
331,667
+59,671
| +22% | +$154K |
|
3996
State Street SPDR S&P Emerging Asia Pacific ETF
GMF
$440M
| $1.08M | ﹤0.01% |
11,106
| – | – |
|
3997
Opendoor
OPEN
$3.54B
| $1.08M | ﹤0.01% |
422,503
+169,845
| +67% | +$612K |
|
3998
Installed Building Products
IBP
$6.54B
| $1.08M | ﹤0.01% |
8,637
-13,865
| -62% | -$1.96M |
|
3999
Eldorado Gold
EGO
$10B
| $1.08M | ﹤0.01% |
120,994
+54,965
| +83% | +$535K |
|
4000
Teekay Tankers
TNK
$2.9B
| $1.08M | ﹤0.01% |
25,852
+509
| +2% | +$20.8K |
|
Similar funds
UBS Group's Q3 2023 Portfolio in Review
As of Q3 2023, UBS Group held 10,416 positions worth $290B, down 2% from $296B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q3 2023 filing shows 1,615 new, 3,254 increased, 4,100 reduced and 999 closed positions. Its largest new stake was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M. The largest sale was NVIDIA, an estimated $538M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2023 buy was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M.
- UBS Group added most to Invesco QQQ Trust in Q3 2023, an estimated $440M increase.
- UBS Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $538M.
- UBS Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $245M.
- UBS Group's ten largest holdings make up 15% of its $290B portfolio in Q3 2023.
- UBS Group opened 1,615 new positions and closed 999 in Q3 2023.
- UBS Group's portfolio value fell 2% quarter-over-quarter to $290B.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.